Rubric Capital Management LP

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$23.45M
Insider Sells Quantity
2
Insider Sells Sum
$1.04B

Insider Activity of Rubric Capital Management LP

According to the SEC Form 4 filings, Rubric Capital Management LP, being in a position of

  1. 10 percent owner at Talen Energy Corporation,
    оver the last 12 months, has bought 0 shares, and sold 4893507 shares for $1,000M,
    over all time since 2024-12-13, has bought 0 shares, and sold 4893507 shares for $1,000M.

The largest purchase of all time was on 2022-10-28 and amounted to 7000 shares of TherapeuticsMD, Inc. for $7M.

The largest sale of all time was on 2024-12-13 and amounted to 4893507 shares of Talen Energy Corporation for $1,000M.

Biography of Rubric Capital Management LP

No biography is available at this moment.

2024-12-13SaleTalen Energy Corporation
TLN
10 percent owner
4.89M
9.3972%
$204.35$1,000M-0.78%
2022-12-30SaleTherapeuticsMD, Inc.
TXMD
director
29,000
$1,333.00$38.66M-31.84%
2022-12-09PurchaseTherapeuticsMD, Inc.
TXMD
director
14,825
0.1558%
$6.09$90,284-39.72%
2022-12-08PurchaseTherapeuticsMD, Inc.
TXMD
director
300
0.0032%
$5.83$1,749-35.2%
2022-12-07PurchaseTherapeuticsMD, Inc.
TXMD
director
20,113
0.2099%
$5.66$113,890-35.44%
2022-10-28PurchaseTherapeuticsMD, Inc.
TXMD
director
7,000
$1,000.00$7M-32.38%
2021-12-16PurchaseRadius Health, Inc.
RDUS
10 percent owner
146,685
0.1881%
$7.07$1.04M-24.46%
2021-12-15PurchaseRadius Health, Inc.
RDUS
10 percent owner
180,744
0.2218%
$6.77$1.22M-23.29%
2021-12-14PurchaseRadius Health, Inc.
RDUS
10 percent owner
94,103
0.1162%
$6.81$640,936-23.5%
2021-12-13PurchaseRadius Health, Inc.
RDUS
10 percent owner
187,391
0.2405%
$7.08$1.33M-22.89%
2021-12-10PurchaseRadius Health, Inc.
RDUS
10 percent owner
768,171
0.9989%
$7.17$5.51M-23.67%
2021-12-09PurchaseRadius Health, Inc.
RDUS
10 percent owner
264,644
0.3637%
$7.58$2.01M-23.48%
2021-12-08PurchaseRadius Health, Inc.
RDUS
10 percent owner
560,691
0.815%
$8.02$4.5M-24.86%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.